von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). (Q37100261)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2008

Language	Label	Description	Also known as
English	von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).	scientific article published on March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

8

object named as

J E Sadler

1 reference

Europe PubMed Central

18 August 2017

author name string

W L Nichols

1

1 reference

Europe PubMed Central

18 August 2017

M B Hultin

2

1 reference

Europe PubMed Central

18 August 2017

A H James

3

1 reference

Europe PubMed Central

18 August 2017

M J Manco-Johnson

4

1 reference

Europe PubMed Central

18 August 2017

R R Montgomery

5

1 reference

Europe PubMed Central

18 August 2017

T L Ortel

6

1 reference

Europe PubMed Central

18 August 2017

M E Rick

7

1 reference

Europe PubMed Central

18 August 2017

M Weinstein

9

1 reference

Europe PubMed Central

18 August 2017

B P Yawn

10

1 reference

Europe PubMed Central

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2008

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

14

1 reference

Europe PubMed Central

18 August 2017

2

1 reference

Europe PubMed Central

18 August 2017

171-232

1 reference

Europe PubMed Central

18 August 2017

Prevalence of von Willebrand disease in children: a multiethnic study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Guidelines for the diagnosis and management of von Willebrand disease in Italy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hereditary pseudohaemophilia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Interactions between von Willebrand factor and Factor VIII: where did they first meet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic induction of a releasable pool of factor VIII in human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Measurement of von Willebrand factor activity: relative effects of ABO blood type and race

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Laboratory diagnosis of congenital von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Atherosclerosis and von Willebrand factor. I. Prevalence of severe von Willebrand's disease in western Europe and Israel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Reduced von Willebrand factor survival in type Vicenza von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Von Willebrand disease type 1: a diagnosis in search of a disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A molecular approach to the classification of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Postoperative thrombocytopenia in type IIB von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

New concepts in von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic determinants of hemostasis phenotypes in Spanish families.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Genetic heterogeneity of severe von Willebrand disease type III in the German population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand syndrome in aortic stenosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Shear stress and von Willebrand factor in health and disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Medical, reproductive and psychosocial experiences of women diagnosed with von Willebrand's disease receiving care in haemophilia treatment centres: a case–control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The Prevalence of von Willebrand disease in women with abnormal uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Frequency of inherited bleeding disorders in women with menorrhagia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Platelet functional defects in women with unexplained menorrhagia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand's disease: an important cause of dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Acquired von Willebrand's syndrome: a single institution experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease type 2A, 2B, and 2M pedigrees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand factor: measuring its antigen or function? Correlation between the level of antigen, activity, and multimer size using various detection systems

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Laboratory diagnosis of von Willebrand's disorder: quality and diagnostic improvements driven by peer review in a multilaboratory test process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Assessment of current diagnostic practice and efficacy in testing for von Willebrand's disorder: results from the second Australasian multi-laboratory survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

External peer review quality assurance testing in von Willebrand disease: the recent experience of the United States College of American Pathologists proficiency testing program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hepatitis viruses: genetic variants and clinical significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 1 von Willebrand disease - a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease: a common pediatric disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Biochemistry and genetics of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Quality control and factor VIII assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

SSC/ISTH classification of hemophilia A: can hemophilia center laboratories achieve the new criteria?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Harmonisation of factor VIII:C assay results: study within the framework of the Dutch project 'Calibration 2000'.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Type 3 von Willebrand disease: assessment of complications and approaches to treatment -- results of a patient and Hemophilia Treatment Center Survey in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Treatment of von Willebrand's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Desmopressin and type II B von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Thrombosis following desmopressin for uremic bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Cysteine-mutations in von Willebrand factor associated with increased clearance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP in Von Willebrand's disease: Repeated administration and the behaviour of the bleeding time

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Perioperative management of von Willebrand's disease in otolaryngologic surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Adenotonsillectomy in children with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of children with von Willebrand disease undergoing adenotonsillectomy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Otolaryngologic surgery in children with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-P).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP-induced hyponatremia in young children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hyponatremia and seizures in young children given DDAVP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP is not a panacea for children with bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Intraoperative cerebral infarction after desmopressin administration in infant with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Females with von Willebrand disease: 72 years as the silent majority

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Use of desmopressin (DDAVP) during early pregnancy in factor VIII-deficient women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP use during pregnancy: an analysis of its safety for mother and child.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease in the developing world

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A comparative in vitro evaluation of six von Willebrand factor concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Risks of transfusion-transmitted infections: 2003.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Haemophilia therapy: assessing the cumulative risk of HIV exposure by cryoprecipitate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hemostatic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The management of von Willebrand's disease-associated gastrointestinal angiodysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and bleeding in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of abnormal uterine bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Testing for von Willebrand disease in women with menorrhagia: a systematic review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical practice. Combination estrogen-progestin oral contraceptives

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Female hormones and thrombosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The safety of oral contraceptives: Epidemiologic insights from the first 30 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Microwave endometrial ablation versus endometrial resection: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Five-year follow-up of endometrial ablation: endometrial coagulation versus endometrial resection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Hysterectomy after endometrial ablation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Recurrent haemoperitoneum in a female patient with type III von Willebrand's disease responded to administration of oral contraceptive

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Haemoperitoneum caused by haemorrhagic corpus luteum in a patient with type 3 von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Obstetric and gynaecological aspects of von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The obstetric and gynaecological management of women with inherited bleeding disorders--review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

How I treat patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Maternal age and fetal loss: population based register linkage study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Maternal and fetal outcomes in pregnancies affected by von Willebrand disease type 2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Two consecutive pregnancies and deliveries in a patient with von Willebrand's disease type 3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The duration and character of postpartum bleeding among breast-feeding women.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Secondary postpartum haemorrhage: incidence, morbidity and current management.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a reivesw of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

von Willebrand disease and pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Clinical management of patients with von Willebrand's disease with a VHP vWF concentrate: the French experience.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Gene therapy. The strange case of chimeraplasty

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Bleeding manifestations in males with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Management of dental extractions in patients with bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-P): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

High dose of tranexamic acid for treatment of severe menorrhagia in patients with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01643.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2007.01643.X

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37100261&oldid=1629746414"